NCT07452783

Brief Summary

This observational study aims to investigate whether periodontal inflammation is associated with alterations in the expression of circadian clock-related genes and proteins in gingival tissues. Circadian rhythms regulate many biological processes, including immune responses and inflammation. Although experimental studies suggest a link between circadian disruption and periodontal disease, human data under controlled chronotype conditions are limited. A total of 60 systemically healthy, non-smoking individuals aged 22-45 years with comparable sleep patterns (intermediate chronotype and 6-9 hours of sleep) were included. Participants were classified as periodontally healthy, gingivitis, or stage III grade B periodontitis according to established diagnostic criteria. Gingival tissue samples were collected during clinically indicated procedures within a standardized morning time window (09:00-11:00). Gene expression levels of circadian clock components (CLOCK, BMAL1, PER1-3, CRY1-2, Rev-Erb-β, ROR-α) and inflammatory mediators (IL-1β, IL-6, TNF-α, NF-κB, IFN-γ, RANKL, OPG) were analyzed using RT-qPCR, Western blot, and ELISA techniques. Associations between molecular findings and clinical periodontal parameters were evaluated. The study seeks to clarify whether periodontal disease itself may disrupt local circadian regulatory mechanisms in gingival tissues.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 2, 2025

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 1, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 5, 2026

Completed
Last Updated

March 6, 2026

Status Verified

March 1, 2026

Enrollment Period

1.1 years

First QC Date

March 1, 2026

Last Update Submit

March 5, 2026

Conditions

Keywords

Circadian RhythmBMAL1CLOCKPer1Per2Per3CRY1CRY2ROR-αRev-Erb-βIL-1βIL-6TNF-αIFN-γRANKLOPGNF-κBPeriodontitisInflammation

Outcome Measures

Primary Outcomes (1)

  • Relative mRNA Expression Levels of Circadian Clock Genes in Gingival Tissue

    Quantitative assessment of BMAL1, CLOCK, PER1, PER2, PER3, CRY1, CRY2, REV-ERBβ, and ROR-α mRNA expression levels in gingival tissue samples using real-time quantitative polymerase chain reaction (RT-qPCR). Expression levels will be calculated as relative fold changes normalized to housekeeping genes and compared among periodontally healthy, gingivitis, and Stage III Grade B periodontitis groups.

    At the time of gingival tissue collection (single time point)

Secondary Outcomes (3)

  • Pro-inflammatory Cytokine Expression Levels

    At the time of tissue collection

  • NF-κB Expression Level

    At the time of tissue collection

  • Bone Metabolism Markers

    At the time of tissue collection

Study Arms (3)

Periodontally Healthy

Systemically healthy individuals with clinically healthy periodontal tissues, no attachment loss, and no radiographic bone loss.

Procedure: Gingival Tissue Biopsy

Gingivitis

Systemically healthy individuals presenting with gingival inflammation without clinical attachment loss or radiographic bone loss.

Procedure: Gingival Tissue Biopsy

Stage III Grade B Periodontitis

Systemically healthy individuals diagnosed with Stage III Grade B periodontitis according to the 2018 classification of periodontal diseases.

Procedure: Gingival Tissue Biopsy

Interventions

Collection of gingival tissue samples from interproximal sites during clinically indicated periodontal procedures for molecular and protein expression analyses.

GingivitisPeriodontally HealthyStage III Grade B Periodontitis

Eligibility Criteria

Age25 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Systemically healthy adult individuals seeking care at the Department of Periodontology, Inonu University Faculty of Dentistry, were recruited. Participants were categorized into three groups based on periodontal status: periodontally healthy, gingivitis, and Stage III Grade B periodontitis according to the 2018 classification of periodontal diseases. All participants required clinically indicated periodontal procedures from which gingival tissue samples could be obtained.

You may qualify if:

  • Adults aged 18 years or older
  • Systemically healthy individuals
  • Presence of at least 20 natural teeth
  • Individuals classified as periodontally healthy, gingivitis, or Stage III Grade B periodontitis according to the 2018 classification of periodontal diseases
  • Willingness to provide written informed consent

You may not qualify if:

  • Presence of any systemic disease affecting periodontal status (e.g., diabetes mellitus, autoimmune diseases, cardiovascular diseases)
  • Use of antibiotics or anti-inflammatory medications within the previous 3 months
  • Periodontal therapy within the last 6 months
  • Current smokers or individuals who quit smoking within the past 5 years
  • Pregnancy or lactation
  • Use of medications known to influence immune or inflammatory responses
  • History of systemic conditions that may affect wound healing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inonu University Faculty of Dentistry

Malatya, 44210, Turkey (Türkiye)

Location

Related Publications (6)

  • Kapila YL. Oral health's inextricable connection to systemic health: Special populations bring to bear multimodal relationships and factors connecting periodontal disease to systemic diseases and conditions. Periodontol 2000. 2021 Oct;87(1):11-16. doi: 10.1111/prd.12398.

    PMID: 34463994BACKGROUND
  • Chapple ILC, Mealey BL, Van Dyke TE, Bartold PM, Dommisch H, Eickholz P, Geisinger ML, Genco RJ, Glogauer M, Goldstein M, Griffin TJ, Holmstrup P, Johnson GK, Kapila Y, Lang NP, Meyle J, Murakami S, Plemons J, Romito GA, Shapira L, Tatakis DN, Teughels W, Trombelli L, Walter C, Wimmer G, Xenoudi P, Yoshie H. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018 Jun;89 Suppl 1:S74-S84. doi: 10.1002/JPER.17-0719.

    PMID: 29926944BACKGROUND
  • Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol. 2010;72:517-49. doi: 10.1146/annurev-physiol-021909-135821.

    PMID: 20148687BACKGROUND
  • Hergenhan S, Holtkamp S, Scheiermann C. Molecular Interactions Between Components of the Circadian Clock and the Immune System. J Mol Biol. 2020 May 29;432(12):3700-3713. doi: 10.1016/j.jmb.2019.12.044. Epub 2020 Jan 10.

    PMID: 31931006BACKGROUND
  • Hastings M, O'Neill JS, Maywood ES. Circadian clocks: regulators of endocrine and metabolic rhythms. J Endocrinol. 2007 Nov;195(2):187-98. doi: 10.1677/JOE-07-0378.

    PMID: 17951531BACKGROUND
  • Czeisler CA, Duffy JF, Shanahan TL, Brown EN, Mitchell JF, Rimmer DW, Ronda JM, Silva EJ, Allan JS, Emens JS, Dijk DJ, Kronauer RE. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science. 1999 Jun 25;284(5423):2177-81. doi: 10.1126/science.284.5423.2177.

    PMID: 10381883BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Gingival tissue biopsy samples obtained from interproximal sites during clinically indicated periodontal procedures. Samples were immediately stored at -80°C for subsequent RNA extraction, gene expression analysis (RT-qPCR), protein analysis (Western blot), and cytokine quantification (ELISA).

MeSH Terms

Conditions

GingivitisPeriodontitisInflammation

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Cuneyt A Aral, Professor, DDS, PhD

    Inonu University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Department of Periodontology

Study Record Dates

First Submitted

March 1, 2026

First Posted

March 5, 2026

Study Start

January 20, 2024

Primary Completion

March 2, 2025

Study Completion

December 1, 2025

Last Updated

March 6, 2026

Record last verified: 2026-03

Locations